Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size The future of US stocks fell on Wednesday morning, as Wall Street was concerned about continuing tensions between the US and China, as well as continuing fears about the coronavirus and the cost it has affected. to the economy. On the US-China front, tensions escalated after the US …
Read More »
The United States will pay $ 1.95 billion for Pfizer to produce and deliver 100 million doses of its candidate vaccine Covid-19 in the US if proven to be safe and effective in humans, the government announced Wednesday. Under the agreement, the United States can purchase an additional 500 million …
Read More »
While markets reacted positively this week to promising news of possible developing coronavirus vaccines, a leading economist warned that the economic impact of the pandemic will be here for a long time. A large number of small businesses that closed in March when restrictions on social movements went into effect …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »